{"id":62549,"date":"2026-04-07T21:09:04","date_gmt":"2026-04-07T13:09:04","guid":{"rendered":"https:\/\/flcube.com\/?p=62549"},"modified":"2026-04-07T21:09:06","modified_gmt":"2026-04-07T13:09:06","slug":"genesis-medtech-acquires-controlling-stake-in-tuge-healthcare-gaining-chinas-first-domestic-4k3dfluorescence-endoscopic-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=62549","title":{"rendered":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform"},"content":{"rendered":"\n<p><strong>Genesis MedTech<\/strong>, a Singapore-based medical device innovator, has acquired a <strong>controlling stake<\/strong> in <strong>Nanjing TUGE Healthcare Co., Ltd.<\/strong>, a Chinese hard-tech leader in <strong>domestic endoscopic imaging<\/strong>. The move grants Genesis immediate access to TUGE\u2019s flagship <strong>\u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d<\/strong>\u2014the <strong>first domestically developed and NMPA-approved<\/strong> platform of its kind in China.<\/p>\n\n\n\n<p>Founded in 2018, TUGE Healthcare holds <strong>over 60 invention patents<\/strong> and specializes in the full-stack R&amp;D, manufacturing, and commercialization of <strong>minimally invasive imaging systems<\/strong>. The acquisition accelerates Genesis MedTech\u2019s strategy to localize high-end surgical visualization in Asia while expanding its footprint in China\u2019s $3.2 billion endoscopy market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-amp-asset-highlights\">Transaction &amp; Asset Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>Genesis MedTech (Singapore)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Nanjing TUGE Healthcare Co., Ltd.<\/td><\/tr><tr><td><strong>Stake Acquired<\/strong><\/td><td>Controlling interest (majority ownership)<\/td><\/tr><tr><td><strong>Key Product<\/strong><\/td><td>4K+3D+Fluorescence Three-in-One Rigid Endoscopic Camera System<\/td><\/tr><tr><td><strong>Regulatory Milestone<\/strong><\/td><td>NMPA approval granted in 2023 \u2014 <strong>first domestic triple-modality system<\/strong> in China<\/td><\/tr><tr><td><strong>IP Portfolio<\/strong><\/td><td>60+ invention patents covering optical design, real-time fusion algorithms, and fluorescence excitation modules<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-differentiation\">Technology Differentiation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Triple-Modality Imaging<\/strong>: Simultaneous <strong>ultra-HD 4K resolution<\/strong>, <strong>true stereoscopic 3D depth perception<\/strong>, and <strong>near-infrared (NIR) fluorescence guidance<\/strong> in a single rigid scope\u2014previously only available via imported systems from Olympus, Karl Storz, and Stryker<\/li>\n\n\n\n<li><strong>Clinical Value<\/strong>: Enables precise tumor margin delineation (via fluorescence), enhanced spatial awareness (3D), and superior tissue detail (4K), particularly in <strong>hepato-biliary, oncologic, and urologic surgeries<\/strong><\/li>\n\n\n\n<li><strong>Localization Advantage<\/strong>: Fully designed and manufactured in China, reducing supply chain risk and enabling faster customization for local hospital workflows<\/li>\n\n\n\n<li><strong>Cost Positioning<\/strong>: Priced <strong>~30% below<\/strong> comparable imported systems, with compatible reusable scopes lowering total cost of ownership<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Access<\/strong>: Genesis gains a ready-to-scale commercial channel in China\u2019s public hospital procurement system, where \u201cdomestically produced\u201d status confers bidding advantages<\/li>\n\n\n\n<li><strong>R&amp;D Synergy<\/strong>: TUGE\u2019s imaging stack will be integrated with Genesis\u2019 robotic-assisted surgery and AI analytics platforms under development<\/li>\n\n\n\n<li><strong>Export Potential<\/strong>: The system is undergoing CE certification, with plans to target Southeast Asia, Middle East, and Latin America by late 2026<\/li>\n\n\n\n<li><strong>Competitive Shift<\/strong>: Challenges Western dominance in high-end endoscopy, signaling China\u2019s growing capability in complex medtech hardware<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking information regarding product commercialization, regulatory clearances, and market expansion. Actual results may vary due to integration risks, competitive response, and healthcare policy changes.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE&#8230;<\/p>\n","protected":false},"author":1,"featured_media":62552,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[256,4681],"class_list":["post-62549","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-genesis-medtech","tag-tuge-healthcare"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE Healthcare Co., Ltd., a Chinese hard-tech leader in domestic endoscopic imaging. The move grants Genesis immediate access to TUGE\u2019s flagship \u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d\u2014the first domestically developed and NMPA-approved platform of its kind in China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=62549\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform\" \/>\n<meta property=\"og:description\" content=\"Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE Healthcare Co., Ltd., a Chinese hard-tech leader in domestic endoscopic imaging. The move grants Genesis immediate access to TUGE\u2019s flagship \u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d\u2014the first domestically developed and NMPA-approved platform of its kind in China.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=62549\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T13:09:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T13:09:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform\",\"datePublished\":\"2026-04-07T13:09:04+00:00\",\"dateModified\":\"2026-04-07T13:09:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549\"},\"wordCount\":391,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0702.webp\",\"keywords\":[\"Genesis MedTech\",\"TUGE Healthcare\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62549#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=62549\",\"name\":\"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0702.webp\",\"datePublished\":\"2026-04-07T13:09:04+00:00\",\"dateModified\":\"2026-04-07T13:09:06+00:00\",\"description\":\"Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE Healthcare Co., Ltd., a Chinese hard-tech leader in domestic endoscopic imaging. The move grants Genesis immediate access to TUGE\u2019s flagship \u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d\u2014the first domestically developed and NMPA-approved platform of its kind in China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62549\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0702.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/0702.webp\",\"width\":1080,\"height\":608,\"caption\":\"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62549#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE Healthcare Co., Ltd., a Chinese hard-tech leader in domestic endoscopic imaging. The move grants Genesis immediate access to TUGE\u2019s flagship \u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d\u2014the first domestically developed and NMPA-approved platform of its kind in China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=62549","og_locale":"en_US","og_type":"article","og_title":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform","og_description":"Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE Healthcare Co., Ltd., a Chinese hard-tech leader in domestic endoscopic imaging. The move grants Genesis immediate access to TUGE\u2019s flagship \u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d\u2014the first domestically developed and NMPA-approved platform of its kind in China.","og_url":"https:\/\/flcube.com\/?p=62549","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-07T13:09:04+00:00","article_modified_time":"2026-04-07T13:09:06+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=62549#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=62549"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform","datePublished":"2026-04-07T13:09:04+00:00","dateModified":"2026-04-07T13:09:06+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=62549"},"wordCount":391,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=62549#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp","keywords":["Genesis MedTech","TUGE Healthcare"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=62549#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=62549","url":"https:\/\/flcube.com\/?p=62549","name":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=62549#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=62549#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp","datePublished":"2026-04-07T13:09:04+00:00","dateModified":"2026-04-07T13:09:06+00:00","description":"Genesis MedTech, a Singapore-based medical device innovator, has acquired a controlling stake in Nanjing TUGE Healthcare Co., Ltd., a Chinese hard-tech leader in domestic endoscopic imaging. The move grants Genesis immediate access to TUGE\u2019s flagship \u201c4K+3D+fluorescence three-in-one rigid endoscope system\u201d\u2014the first domestically developed and NMPA-approved platform of its kind in China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=62549#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=62549"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=62549#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp","width":1080,"height":608,"caption":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=62549#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Genesis MedTech Acquires Controlling Stake in TUGE Healthcare, Gaining China\u2019s First Domestic 4K+3D+Fluorescence Endoscopic Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/0702.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62549"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62549\/revisions"}],"predecessor-version":[{"id":62553,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62549\/revisions\/62553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/62552"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}